Coronary disease & ACS

Impact of non-culprit lesion thin-cap fibroatheroma (TCFA) on adverse cardiovascular events in patients with diabetes mellitus who present with acute myocardial infarction

Eur Heart J Cardiovasc ImagingPublished Cohort study

Authors' conclusion

DM patients have a higher incidence of NCL-MACE after AMI, primarily due to increased NCL TCFA prevalence. In both DM and non-DM patients, NCL TCFA worsens long-term prognosis.

Study context

Population
Acute myocardial infarction (AMI) patients undergoing three-vessel optical coherence tomography
Participants
1,312 patients
Exposure
Diabetes mellitus (DM) vs non-DM; NCL TCFA vs no TCFA
  • DMn = 311
Outcome
NCL-MACE:
  • Cardiac death
  • Non-fatal myocardial infarction (MI)
  • Unplanned coronary revascularization
Follow-up
Median 4.1 years (IQR: 3.0-5.0 years)
Methodological detailsthree-vessel optical coherence tomography (OCT)
  • Three-vessel OCT

Main finding

As reported in the abstract

NCL-MACE · median 4.1 years
DM vs Non-DMEstimate (95% CI)
NCL-MACE
HR 2.10(1.23–3.57)
After adjusting for TCFA
adjusted HR 1.66(0.94–2.94)

Observational data: associations, not effects.

Further findings

NCL TCFA prevalence, patient level

P < 0.001

NCL TCFA prevalence, lesion level

P < 0.001

OutcomeDMNon-DMEstimate
Non-fatal MI (NCL)3.7%1.0%HR 3.33 (95% CI 1.25–8.87)
Association of DM with TCFAadjusted OR 1.61 (95% CI 1.22–2.13)

Original publication

Impact of non-culprit lesion TCFA on adverse cardiovascular events in patients with diabetes mellitus who present with acute myocardial infarction. Eur Heart J Cardiovasc Imaging. Published 28 July 2025. doi:10.1093/ehjci/jeaf219

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.